DANIEL RASMUSSEN
Verdad Advisers, Lp
Assets Managed
$88.833M
Holdings
179
Last Quarter
2026 - Q1
Filed Date
20d ago
Growth Rate
1.66%(2Q avg: 9.17%)
Sustained Growth
2 quarters
Portfolio positions
This chart displays the top 10 holdings in Verdad Advisers, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 179 positions.
Assets under management
The assets under management (AUM) of Verdad Advisers, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 88.833M in assets, with a quarterly growth rate of 1.66% and a 2-quarter average growth rate of 9.17%. The portfolio is managed by DANIEL RASMUSSEN, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
BLTE Belite Bio Inc - Adr
| 2.48% | $2.202M 13,813 shares@ $159.45 avg price | New Position |
STT State Street Corp
| 2.38% | $2.109M 16,665 shares@ $126.56 avg price | New Position |
ATHM Autohome Inc-adr
| 2.38% | $2.107M 121,317 shares@ $17.37 avg price | New Position |
RVMD Revolution Medicines Inc
| 2.37% | $2.098M 21,572 shares@ $97.25 avg price | New Position |
ZYME Zymeworks Inc
| 2.34% | $2.071M 82,698 shares@ $25.05 avg price | New Position |
CALM Cal-maine Foods Inc
| 2.2% | $1.95M 24,637 shares@ $79.16 avg price | Increased 19.31% |
ZM Zoom Communications Inc
| 1.96% | $1.735M 21,580 shares@ $80.39 avg price | Increased 3.11% |
CRC California Resources Corp
| 1.76% | $1.557M 22,500 shares@ $69.22 avg price | Increased 213.38% |
TENX Tenax Therapeutics Inc
| 1.72% | $1.524M 95,330 shares@ $16.0 avg price | New Position |
ACAD Acadia Pharmaceuticals Inc
| 1.72% | $1.52M 68,290 shares@ $22.26 avg price | New Position |
1-10 of 179